Understanding the development of sarcopenic obesity

References

• Ortman VAV JA, Hogan H. An aging nation: the older population in the United States. Current Population Reports: (WA). DC; 2014. p. 1–28.
   Google Scholar
• Stierman B, Afful J, Carroll MD, et al. National Center for Health Statistics (U.S.). National Health and Nutrition Examination Survey 2017–March 2020 Prepandemic Data Files Development of Files and Prevalence Estimates for Selected Health Outcomes. National Health Statistics Reports; 2021. (NHSR No. 158). https://stacks.cdc.gov/view/cdc/106273
   Google Scholar
• Nascimento CM, Ingles M, Salvador-Pascual A, et al. Sarcopenia, frailty and their prevention by exercise. Free Radic Biol Med. 2019 Feb 20;132:42–49. doi: 10.1016/j.freeradbiomed.2018.08.035
   PubMed Web of Science ®Google Scholar
• Larsson L, Degens H, Li M, et al. Sarcopenia: aging-related loss of muscle mass and function. Physiol Rev. 2019 Jan 1;99(1):427–511. doi: 10.1152/physrev.00061.2017
   PubMed Web of Science ®Google Scholar
• Donini LM, Busetto L, Bischoff SC, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Clin Nutr. 2022 Apr;41(4):990–1000. doi: 10.1016/j.clnu.2021.11.014
   PubMed Web of Science ®Google Scholar
• Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018 2018-Sep-1;14(9):513–537. doi: 10.1038/s41574-018-0062-9
   PubMed Web of Science ®Google Scholar
• ! INVALID CITATION! [7].
   Google Scholar
• Roderka MN, Puri S, Batsis JA. Addressing obesity to promote healthy Aging. Clin Geriatr Med. 2020 Nov;36(4):631–643. doi: 10.1016/j.cger.2020.06.006
   PubMed Web of Science ®Google Scholar
• Germain CM, Vasquez E, Batsis JA. Physical activity, central adiposity, and functional limitations in community-dwelling older adults. J Geriatr Phys Ther. 2016 Apr;39(2):71–76. doi: 10.1519/JPT.0000000000000051
   PubMed Web of Science ®Google Scholar
• Gao Q, Mei F, Shang Y, et al. Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis. Clin Nutr. 2021 Jul;40(7):4633–4641. doi: 10.1016/j.clnu.2021.06.009
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16–31. doi: 10.1093/ageing/afy169
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010 Jul;39(4):412–423. doi: 10.1093/ageing/afq034
   PubMed Web of Science ®Google Scholar
• Bhasin S, Travison TG, Manini TM, et al. Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium. J Am Geriatr Soc. 2020 2020-Jul-1;68(7):1410–1418. doi: 10.1111/jgs.16372
   PubMed Web of Science ®Google Scholar
• Cawthon PM, Visser M, Arai H, et al. Defining terms commonly used in sarcopenia research: a glossary proposed by the Global Leadership in Sarcopenia (GLIS) Steering Committee. Eur Geriatr Med. 2022 2022-Nov-29;13(6):1239–1244. doi: 10.1007/s41999-022-00706-5
   PubMed Web of Science ®Google Scholar
• Caleyachetty R, Barber TM, Mohammed NI, et al. Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2021 Jul;9(7):419–426. doi: 10.1016/S2213-8587(21)00088-7
   PubMed Web of Science ®Google Scholar
• Batsis JA, Mackenzie TA, Bartels SJ, et al. Diagnostic accuracy of body mass index to identify obesity in older adults: NHANES 1999-2004. Int J Obes (Lond). 2016 May;40(5):761–767. doi: 10.1038/ijo.2015.243
   PubMed Web of Science ®Google Scholar
• Winter JE, MacInnis RJ, Wattanapenpaiboon N, et al. BMI and all-cause mortality in older adults: a meta-analysis. Am J Clin Nutr. 2014 Apr;99(4):875–890. doi: 10.3945/ajcn.113.068122
   PubMed Web of Science ®Google Scholar
• Batsis JA, Barre LK, Mackenzie TA, et al. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the national health and nutrition examination survey 1999-2004. J Am Geriatr Soc. 2013 Jun;61(6):974–980. doi: 10.1111/jgs.12260
   PubMed Web of Science ®Google Scholar
• Ji T, Li Y, Ma L. Response to letter to the editor, “sarcopenic obesity: an emerging public health problem, but an answer appears to be available”. Aging Dis. 2022 Jun;13(3):637–638. doi: 10.14336/AD.2021.1120-1
   PubMedGoogle Scholar
• Gortan Cappellari G, Guillet C, Poggiogalle E, et al. Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) - proceedings from the SOGLI consortium meeting in rome November 2022. Clin Nutr. 2023 May;42(5):687–699. doi: 10.1016/j.clnu.2023.02.018
   PubMed Web of Science ®Google Scholar
• Baumgartner RN, Wayne SJ, Waters DL, et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly [article]. Obes Res. 2004 Dec;12(12):1995–2004. doi: 10.1038/oby.2004.250
   PubMedGoogle Scholar
• Wallengren O, Bosaeus I, Frändin K, et al. Comparison of the 2010 and 2019 diagnostic criteria for sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP) in two cohorts of Swedish older adults. BMC Geriatr. 2021 2021-Dec-1;21(1). Doi:10.1186/s12877-021-02533-y
   PubMed Web of Science ®Google Scholar
• Hirani V, Naganathan V, Blyth F, et al. Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: the concord health and ageing in men project. Age Ageing. 2017 May 1;46(3):413–420. doi: 10.1093/ageing/afw214
   PubMed Web of Science ®Google Scholar
• Davison KK, Ford ES, Cogswell ME, et al. Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. J Am Geriatr Soc. 2002 Nov;50(11):1802–1809. doi: 10.1046/j.1532-5415.2002.50508.x
   PubMed Web of Science ®Google Scholar
• Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the national health and nutrition examination survey III. PLoS One. 2010 May 26;5(5):e10805. doi: 10.1371/journal.pone.0010805
   PubMed Web of Science ®Google Scholar
• Khadra D, Itani L, Tannir H, et al. Association between sarcopenic obesity and higher risk of type 2 diabetes in adults: a systematic review and meta-analysis. World J Diabetes. 2019 May 15;10(5):311–323. doi: 10.4239/wjd.v10.i5.311
   PubMed Web of Science ®Google Scholar
• Han K, Park YM, Kwon HS, et al. Sarcopenia as a determinant of blood pressure in older Koreans: findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008-2010. PLoS One. 2014;9(1):e86902. doi: 10.1371/journal.pone.0086902
   PubMed Web of Science ®Google Scholar
• Chin SO, Rhee SY, Chon S, et al. Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009. PLoS One. 2013;8(3):e60119. doi: 10.1371/journal.pone.0060119
   PubMed Web of Science ®Google Scholar
• Baek SJ, Nam GE, Han KD, et al. Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008-2010 Korea National Health and Nutrition Examination Survey. J Endocrinol Invest. 2014 Mar;37(3):247–260. doi: 10.1007/s40618-013-0011-3
   PubMed Web of Science ®Google Scholar
• Messier V, Karelis AD, Lavoie ME, et al. Metabolic profile and quality of life in class I sarcopenic overweight and obese postmenopausal women: a MONET study. Appl Physiol Nutr Metab. 2009 Feb;34(1):18–24. doi: 10.1139/H08-135
   PubMed Web of Science ®Google Scholar
• Park SH, Park JH, Song PS, et al. Sarcopenic obesity as an independent risk factor of hypertension. J Am Soc Hypertens. 2013;7(6):420–425. doi: 10.1016/j.jash.2013.06.002
   PubMed Web of Science ®Google Scholar
• Lim S, Kim JH, Yoon JW, et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care. 2010 Jul;33(7):1652–1654. doi: 10.2337/dc10-0107
   PubMed Web of Science ®Google Scholar
• Khadra D, Itani L, Chebaro Y, et al. Association between sarcopenic obesity and metabolic syndrome in adults: a systematic review and meta-analysis. Curr Cardiol Rev. 2020;16(2):153–162. doi: 10.2174/1573403X16666200214104122
   PubMed Web of Science ®Google Scholar
• Atkins JL, Whincup PH, Morris RW, et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. 2014 Feb;62(2):253–260. doi: 10.1111/jgs.12652
   PubMed Web of Science ®Google Scholar
• Atkins JL, Wannamathee SG. Sarcopenic obesity in ageing: cardiovascular outcomes and mortality.British Journal Of Nutrition. 2020 2020-Nov-28;124(10):1102–1113. doi: 10.1017/S0007114520002172
   PubMed Web of Science ®Google Scholar
• Farmer RE, Mathur R, Schmidt AF, et al. Associations between measures of sarcopenic obesity and risk of cardiovascular disease and mortality: a cohort study and mendelian randomization analysis using the UK Biobank. J Am Heart Assoc. 2019 Jul 2;8(13):e011638. doi: 10.1161/JAHA.118.011638
   PubMed Web of Science ®Google Scholar
• Stephen WC, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging. 2009 May;13(5):460–466. doi: 10.1007/s12603-009-0084-z
   PubMed Web of Science ®Google Scholar
• Lutski M, Weinstein G, Tanne D, et al. Overweight, obesity, and late-life Sarcopenia among men with cardiovascular disease, Israel. Prev Chronic Dis. 2020 Dec 24;17:E164. doi: 10.5888/pcd17.200167
   PubMed Web of Science ®Google Scholar
• Xia MF, Chen LY, Wu L, et al. Sarcopenia, sarcopenic overweight/obesity and risk of cardiovascular disease and cardiac arrhythmia: a cross-sectional study. Clin Nutr. 2021 Feb;40(2):571–580. doi: 10.1016/j.clnu.2020.06.003
   PubMed Web of Science ®Google Scholar
• Billingsley HE, Del Buono MG, Canada JM, et al. Sarcopenic obesity is associated with reduced cardiorespiratory fitness compared with nonsarcopenic obesity in patients with heart failure with reduced ejection fraction. Circ Heart Fail. 2022 Oct;15(10):e009518. doi: 10.1161/CIRCHEARTFAILURE.122.009518
   PubMed Web of Science ®Google Scholar
• Saito H, Matsue Y, Kamiya K, et al. Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF. BMC Geriatr. 2022 Jul 5;22(1):556. doi: 10.1186/s12877-022-03168-3
   PubMed Web of Science ®Google Scholar
• Evans K, Abdelhafiz D, Abdelhafiz AH. Sarcopenic obesity as a determinant of cardiovascular disease risk in older people: a systematic review. Postgrad Med. 2021 Nov;133(8):831–842. doi: 10.1080/00325481.2021.1942934
   PubMed Web of Science ®Google Scholar
• Gandham A, Mesinovic J, Jansons P, et al. Falls, fractures, and areal bone mineral density in older adults with sarcopenic obesity: a systematic review and meta-analysis. Obes Rev. 2021 May;22(5):e13187. doi: 10.1111/obr.13187
   PubMed Web of Science ®Google Scholar
• Turcotte AF, O’Connor S, Morin SN, et al. Association between obesity and risk of fracture, bone mineral density and bone quality in adults: a systematic review and meta-analysis. PLoS One. 2021;16(6):e0252487. doi: 10.1371/journal.pone.0252487
   PubMed Web of Science ®Google Scholar
• Rinonapoli G, Pace V, Ruggiero C, et al. Obesity and bone: a complex relationship. Int J Mol Sci. 2021 Dec 20;22(24):13662. doi: 10.3390/ijms222413662
   PubMed Web of Science ®Google Scholar
• He C, He W, Hou J, et al. Bone and muscle crosstalk in Aging. Front Cell Dev Biol. 2020;8:585644. doi: 10.3389/fcell.2020.585644
   PubMed Web of Science ®Google Scholar
• Lee S, Kim TN, Kim SH. Sarcopenic obesity is more closely associated with knee osteoarthritis than is nonsarcopenic obesity: a cross-sectional study [comparative study]. Arthritis & Rheumatism. 2012 Dec;64(12):3947–3954. doi: 10.1002/art.37696
   PubMed Web of Science ®Google Scholar
• Balogun SA, Graves SE, Lorimer M, et al. Do older adults with low muscle mass or strength, in the presence of obesity, have an increased risk of Joint replacement over 13 years? Calcif Tissue Int. 2020 Jul;107(1):10–17. doi: 10.1007/s00223-020-00698-z
   PubMed Web of Science ®Google Scholar
• Kim HI, Ahn SH, Kim Y, et al. Effects of sarcopenia and sarcopenic obesity on joint pain and degenerative osteoarthritis in postmenopausal women. Sci Rep. 2022 Aug 8;12(1):13543. doi: 10.1038/s41598-022-17451-1
   PubMed Web of Science ®Google Scholar
• Godziuk K, Prado CM, Woodhouse LJ, et al. The impact of sarcopenic obesity on knee and hip osteoarthritis: a scoping review. BMC Musculoskelet Disord. 2018 Jul 28;19(1):271. doi: 10.1186/s12891-018-2175-7
   PubMedGoogle Scholar
• Hamer M, Batty GD, Kivimaki M. Sarcopenic obesity and risk of new onset depressive symptoms in older adults: English longitudinal study of ageing. Int J Obes (Lond). 2015 Dec;39(12):1717–1720. doi: 10.1038/ijo.2015.124
   PubMed Web of Science ®Google Scholar
• Ishii S, Chang C, Tanaka T, et al. The Association between sarcopenic obesity and depressive symptoms in older Japanese adults. PLoS One. 2016;11(9):e0162898. doi: 10.1371/journal.pone.0162898
   PubMed Web of Science ®Google Scholar
• Venant V, Pouget M, Lahaye C, et al. Depression severity as a risk factor of sarcopenic obesity in Morbidly obese patients. J Nutr Health Aging. 2019;23(8):761–767. doi: 10.1007/s12603-019-1218-6
   PubMed Web of Science ®Google Scholar
• Kokkeler KJE, van den Berg KS, Comijs HC, et al. Sarcopenic obesity predicts nonremission of late-life depression. Int J Geriatr Psychiatry. 2019 Aug;34(8):1226–1234. doi: 10.1002/gps.5121
   PubMed Web of Science ®Google Scholar
• Li Z, Tong X, Ma Y, et al. Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):128–144. doi: 10.1002/jcsm.12908
   PubMed Web of Science ®Google Scholar
• Pilati I, Slee A, Frost R. Sarcopenic obesity and depression: a systematic review. J Frailty Aging. 2022;11(1):51–58. doi: 10.14283/jfa.2021.39
   PubMed Web of Science ®Google Scholar
• Mei KL, Batsis JA, Mills JB, et al. Sarcopenia and sarcopenic obesity: do they predict inferior oncologic outcomes after gastrointestinal cancer surgery? Perioper Med. 2016;5(1):30. doi: 10.1186/s13741-016-0052-1
   Google Scholar
• Kim J, Han SH, Kim HI. Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning. J Surg Oncol. 2021 Dec;124(8):1347–1355. doi: 10.1002/jso.26668
   PubMed Web of Science ®Google Scholar
• EH VR, Bours MJL, Te Molder MEM, et al. Associations of adipose and muscle tissue parameters at colorectal cancer diagnosis with long-term health-related quality of life. Qual Life Res. 2017 Jul;26(7):1745–1759. doi: 10.1007/s11136-017-1539-z
   PubMed Web of Science ®Google Scholar
• Kroh A, Uschner D, Lodewick T, et al. Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients. Hepatobiliary Pancreat Dis Int. 2019 Feb;18(1):28–37. doi: 10.1016/j.hbpd.2018.07.008
   PubMed Web of Science ®Google Scholar
• Gortan Cappellari G, Brasacchio C, Laudisio D, et al. Sarcopenic obesity: what about in the cancer setting? Nutrition. 2022 Jun;98:111624.
   PubMed Web of Science ®Google Scholar
• Silveira EA, da Silva Filho RR, Spexoto MCB, et al. The role of sarcopenic obesity in cancer and cardiovascular disease: a synthesis of the evidence on pathophysiological aspects and clinical implications. Int J Mol Sci. 2021 Apr 21;22(9):4339. doi: 10.3390/ijms22094339
   PubMed Web of Science ®Google Scholar
• Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008 Jul;9(7):629–635. doi: 10.1016/S1470-2045(08)70153-0
   PubMed Web of Science ®Google Scholar
• Prado CM, Maia YL, Ormsbee M, et al. Assessment of nutritional status in cancer–the relationship between body composition and pharmacokinetics. Anticancer Agents Med Chem. 2013 Oct;13(8):1197–1203. doi: 10.2174/18715206113139990322
   PubMed Web of Science ®Google Scholar
• Prado CM, Lieffers JR, Bowthorpe L, et al. Sarcopenia and physical function in overweight patients with advanced cancer. Can J Diet Pract Res. 2013;74(2):69–74. doi: 10.3148/74.2.2013.69
   PubMed Web of Science ®Google Scholar
• Meza-Junco J, Montano-Loza AJ, Baracos VE, et al. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol. 2013;47(10):861–870. doi: 10.1097/MCG.0b013e318293a825
   PubMed Web of Science ®Google Scholar
• Silva Neto LS, Karnikowiski MG, Tavares AB, et al. Association between sarcopenia, sarcopenic obesity, muscle strength and quality of life variables in elderly women. Rev Bras Fisioter. 2012;16(5):360–367. doi: 10.1590/S1413-35552012005000044
   PubMedGoogle Scholar
• Ware JE Jr., Kosinski M, Bjorner JB, et al. User’s manual for the SF-12v2 health survey. Lincoln: Quality Metric Incorporated; 2009.
   Google Scholar
• Group E. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. 1990 Dec;16(3):199–208.
   PubMed Web of Science ®Google Scholar
• Chang SF, Chiu SC. Effect of resistance training on quality of life in older people with sarcopenic obesity living in long-term care institutions: a quasi-experimental study. J Clin Nurs. 2020 Jul;29(13–14):2544–2556. doi: 10.1111/jocn.15277
   PubMed Web of Science ®Google Scholar
• Itani L, Kreidieh D, El Masri D, et al. The impact of sarcopenic obesity on health-related quality of life of treatment-seeking patients with obesity. Curr Diabetes Rev. 2020;16(6):635–640. doi: 10.2174/1573399816666200211102057
   PubMed Web of Science ®Google Scholar
• Beberashvili I, Azar A, Khatib A, et al. Sarcopenic obesity versus nonobese sarcopenia in hemodialysis patients: differences in nutritional status, quality of life, and clinical outcomes. J Ren Nutr. 2023 Jan;33(1):147–156. doi: 10.1053/j.jrn.2022.05.003
   PubMedGoogle Scholar
• Martínez-Herrera BE, Trujillo-Hernández B, Sat-Muñoz D, et al. Quality of life and functionality of head and neck cancer patients are diminished as a function of sarcopenia and obesity. Ear Nose Throat J. 2022 Feb;28:1455613221076791.
   Google Scholar
• Cawthon PM, Lui LY, McCulloch CE, et al. Sarcopenia and health care utilization in older women. J Gerontol A Biol Sci Med Sci. 2017 Jan;72(1):95–101. doi: 10.1093/gerona/glw118
   PubMed Web of Science ®Google Scholar
• Arensberg MB, Brunton C, Drawert S, et al. Prevalence rates and characteristics of malnutrition, frailty, and other Nutrition and muscle mass-related conditions document potential quality of care gap for medicare patients in US skilled nursing facilities. Geriatrics (Basel). 2022 Mar 31;7(2):42. doi: 10.3390/geriatrics7020042
   PubMedGoogle Scholar
• Janssen I, Shepard DS, Katzmarzyk PT, et al. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004 Jan;52(1):80–85. doi: 10.1111/j.1532-5415.2004.52014.x
   PubMed Web of Science ®Google Scholar
• Akune T, Muraki S, Oka H, et al. Incidence of certified need of care in the long-term care insurance system and its risk factors in the elderly of Japanese population-based cohorts: the ROAD study. Geriatr Gerontol Int. 2014 Jul;14(3):695–701. doi: 10.1111/ggi.12155
   PubMed Web of Science ®Google Scholar
• Bravo-José P, Moreno E, Espert M, et al. Prevalence of sarcopenia and associated factors in institutionalised older adult patients. Clin Nutr ESPEN. 2018 Oct;27:113–119.
   PubMed Web of Science ®Google Scholar
• Nizalova O, Gousia K, Forder J. Effect of body mass on future long-term care use. BMC Geriatr. 2020 Aug 17;20(1):293. doi: 10.1186/s12877-020-01688-4
   PubMed Web of Science ®Google Scholar
• Elkins JS, Whitmer RA, Sidney S, et al. Midlife obesity and long-term risk of nursing home admission. Obesity (Silver Spring). 2006 Aug;14(8):1472–1478. doi: 10.1038/oby.2006.167
   PubMed Web of Science ®Google Scholar
• Valiyeva E, Russell LB, Miller JE, et al. Lifestyle-related risk factors and risk of future nursing home admission. Arch Intern Med. 2006 May 8;166(9):985–990. doi: 10.1001/archinte.166.9.985
   PubMedGoogle Scholar
• Cai S, Rahman M, Intrator O. Obesity and pressure ulcers among nursing home residents. Med care. 2013 Jun;51(6):478–486. doi: 10.1097/MLR.0b013e3182881cb0
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Shaper AG, Lennon L, et al. Decreased muscle mass and increased central adiposity are independently related to mortality in older men. Am J Clin Nutr. 2007 Nov;86(5):1339–1346. doi: 10.1093/ajcn/86.5.1339
   PubMed Web of Science ®Google Scholar
• Batsis JA, Mackenzie TA, Barre LK, et al. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the national health and nutrition examination survey III. Eur J Clin Nutr. 2014 2014-Sep-1;68(9):1001–1007. doi: 10.1038/ejcn.2014.117
   PubMed Web of Science ®Google Scholar
• Hamer M, O’Donovan G. Sarcopenic obesity, weight loss, and mortality: the English longitudinal study of ageing. Am J Clin Nutr. 2017 Jul;106(1):125–129. doi: 10.3945/ajcn.117.152488
   PubMed Web of Science ®Google Scholar
• Zhang L, Lv J, Wang C, et al. Myokine, a key cytokine for physical exercise to alleviate Sarcopenic obesity. Mol Biol Rep. 2022 Dec 26;50(3):2723–2734. doi: 10.1007/s11033-022-07821-3
   PubMed Web of Science ®Google Scholar
• Flegal KM, Shepherd JA, Looker AC, et al. Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr. 2009 Feb;89(2):500–508. doi: 10.3945/ajcn.2008.26847
   PubMed Web of Science ®Google Scholar
• Heo M, Faith MS, Pietrobelli A, et al. Percentage of body fat cutoffs by sex, age, and race-ethnicity in the US adult population from NHANES 1999-2004. Am J Clin Nutr. 2012 Mar;95(3):594–602. doi: 10.3945/ajcn.111.025171
   PubMed Web of Science ®Google Scholar
• Xu W, Perera S, Medich D, et al. Height loss, vertebral fractures, and the misclassification of osteoporosis. Bone. 2011 Feb;48(2):307–311. doi: 10.1016/j.bone.2010.09.027
   PubMed Web of Science ®Google Scholar
• Stenholm S, Harris TB, Rantanen T, et al. Sarcopenic obesity: definition, cause and consequences [review]. Curr Opin Clin Nutr Metab Care. 2008 Nov;11(6):693–700. doi: 10.1097/MCO.0b013e328312c37d
   PubMed Web of Science ®Google Scholar
• Cartwright MJ, Tchkonia T, Kirkland JL. Aging in adipocytes: potential impact of inherent, depot-specific mechanisms. Exp Gerontol. 2007 Jun;42(6):463–471. doi: 10.1016/j.exger.2007.03.003
   PubMed Web of Science ®Google Scholar
• Kuk JL, Ardern CI. Influence of age on the association between various measures of obesity and all-cause mortality. J Am Geriatr Soc. 2009 Nov;57(11):2077–2084. doi: 10.1111/j.1532-5415.2009.02486.x
   PubMed Web of Science ®Google Scholar
• Sayer AA, Syddall H, Martin H, et al. The developmental origins of sarcopenia. J Nutr Health Aging. 2008 Aug;12(7):427–432. doi: 10.1007/BF02982703
   PubMed Web of Science ®Google Scholar
• Goodpaster BH, Carlson CL, Visser M, et al. Attenuation of skeletal muscle and strength in the elderly: the health ABC study. J Appl Physiol (1985). 2001 Jun;90(6):2157–2165. doi: 10.1152/jappl.2001.90.6.2157
   PubMed Web of Science ®Google Scholar
• Mitchell WK, Williams J, Atherton P, et al. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol. 2012;3:260. doi: 10.3389/fphys.2012.00260
   PubMed Web of Science ®Google Scholar
• Kob R, Fellner C, Bertsch T, et al. Gender-specific differences in the development of sarcopenia in the rodent model of the ageing high-fat rat. J Cachexia Sarcopenia Muscle. 2015 Jun;6(2):181–191. doi: 10.1002/jcsm.12019
   PubMed Web of Science ®Google Scholar
• Kemmler W, von Stengel S, Schoene D. Longitudinal changes in muscle mass and function in older men at increased risk for sarcopenia - the FrOST-Study. J Frailty Aging. 2019;8(2):57–61. doi: 10.14283/jfa.2019.9
   PubMed Web of Science ®Google Scholar
• Kim TN, Park MS, Lim KI, et al. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean sarcopenic obesity study. Clin Endocrinol (Oxf). 2013 Apr;78(4):525–532. doi: 10.1111/j.1365-2265.2012.04433.x
   PubMed Web of Science ®Google Scholar
• Jyväkorpi SK, Urtamo A, Kivimäki M, et al. Macronutrient composition and sarcopenia in the oldest-old men: the Helsinki Businessmen study (HBS). Clin Nutr. 2020 12;39(12):3839–3841. doi: 10.1016/j.clnu.2020.04.024
   PubMed Web of Science ®Google Scholar
• Custodero C, Mankowski RT, Lee SA, et al. Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: a systematic review and meta-analysis. Ageing Res Rev. 2018 2018-Sep-1;46:42–59.
   PubMed Web of Science ®Google Scholar
• Cornish SM, Cordingley DM, Shaw KA, et al. Effects of omega-3 supplementation alone and combined with resistance exercise on skeletal muscle in older adults: a systematic review and meta-analysis. Nutrients. 2022 2022-May-26;14(11):2221. doi: 10.3390/nu14112221
   PubMed Web of Science ®Google Scholar
• Ganapathy A, Nieves JW. Nutrition and sarcopenia—what do we know?Nutrients. 2020 2020-Jun-11;12(6):1755. doi: 10.3390/nu12061755
   PubMed Web of Science ®Google Scholar
• Neville CE, Young IS, Gilchrist SECM, et al. Effect of increased fruit and vegetable consumption on physical function and muscle strength in older adults. Age. 2013 2013-Dec-1;35(6):2409–2422. doi: 10.1007/s11357-013-9530-2
   PubMedGoogle Scholar
• Yin YH, Liu JYW, Välimäki M. Effectiveness of non-pharmacological interventions on the management of sarcopenic obesity: a systematic review and meta-analysis. Exp Gerontol. 2020 Jul 1;135:110937. doi: 10.1016/j.exger.2020.110937
   PubMed Web of Science ®Google Scholar
• Alizadeh Pahlavani H. Exercise therapy for people with sarcopenic obesity: Myokines and adipokines as effective actors. Front Endocrinol. 2022;13:811751. doi: 10.3389/fendo.2022.811751
   PubMed Web of Science ®Google Scholar
• Guo A, Li K, Xiao Q. Sarcopenic obesity: Myokines as potential diagnostic biomarkers and therapeutic targets? Exp Gerontol. 2020 Oct 1;139:111022. doi: 10.1016/j.exger.2020.111022
   PubMed Web of Science ®Google Scholar
• Ryu JY, Choi HM, Yang HI, et al. Dysregulated autophagy mediates sarcopenic obesity and its complications via AMPK and PGC1α signaling pathways: potential involvement of gut dysbiosis as a pathological link. Int J Mol Sci. 2020 Sep 19;21(18):6887. doi: 10.3390/ijms21186887
   PubMed Web of Science ®Google Scholar
• Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev. 2017 May;35:200–221. doi: 10.1016/j.arr.2016.09.008
   PubMed Web of Science ®Google Scholar
• McCormick R, Vasilaki A. Age-related changes in skeletal muscle: changes to life-style as a therapy. Biogerontology. 2018 Dec;19(6):519–536. doi: 10.1007/s10522-018-9775-3
   PubMed Web of Science ®Google Scholar
• Tallis J, James RS, Little AG, et al. Early effects of ageing on the mechanical performance of isolated locomotory (EDL) and respiratory (diaphragm) skeletal muscle using the work-loop technique. Am J Physiol Regul Integr Comp Physiol. 2014 Sep 15;307(6):R670–84. doi: 10.1152/ajpregu.00115.2014
   PubMed Web of Science ®Google Scholar
• Renganathan M, Messi ML, Delbono O. Dihydropyridine receptor-ryanodine receptor uncoupling in aged skeletal muscle. J Membr Biol. 1997 Jun 1;157(3):247–253. doi: 10.1007/s002329900233
   PubMed Web of Science ®Google Scholar
• Delrio-Lorenzo A, Rojo-Ruiz J, Alonso MT, et al. Sarcoplasmic reticulum Ca2+ decreases with age and correlates with the decline in muscle function in Drosophila. J Cell Sci. 2020 2020-Jan-1;133(6):jcs240879. doi: 10.1242/jcs.240879
   PubMed Web of Science ®Google Scholar
• Sun N, Youle RJ, Finkel T. The Mitochondrial basis of Aging. Mol Cell. 2016 Mar 3;61(5):654–666. doi: 10.1016/j.molcel.2016.01.028
   PubMed Web of Science ®Google Scholar
• Brack AS, Muñoz-Cánoves P. The ins and outs of muscle stem cell aging. Skelet Muscle. 2016;6(1):1. doi: 10.1186/s13395-016-0072-z
   PubMedGoogle Scholar
• Alway SE, Myers MJ, Mohamed JS. Regulation of satellite cell function in sarcopenia. Front Aging Neurosci. 2014;6:246. doi: 10.3389/fnagi.2014.00246
   PubMed Web of Science ®Google Scholar
• Hill C, James RS, Cox VM, et al. The Effect of increasing age on the concentric and eccentric contractile properties of isolated mouse soleus and extensor digitorum longus muscles. J Gerontol A Biol Sci Med Sci. 2018 Apr 17;73(5):579–587. doi: 10.1093/gerona/glx243
   PubMed Web of Science ®Google Scholar
• Hill C, James RS, Cox VM, et al. Age-related changes in isolated mouse skeletal muscle function are dependent on sex, muscle, and contractility mode. Am J Physiol Regul Integr Comp Physiol. 2020 Sep 1;319(3):R296–R314. doi: 10.1152/ajpregu.00073.2020
   PubMed Web of Science ®Google Scholar
• Metter EJ, Conwit R, Tobin J, et al. Age-associated loss of power and strength in the upper extremities in women and men. J Gerontol A Biol Sci Med Sci. 1997 Sep;52(5):B267–76. doi: 10.1093/gerona/52A.5.B267
   PubMed Web of Science ®Google Scholar
• Foldvari M, Clark M, Laviolette LC, et al. Association of muscle power with functional status in community-dwelling elderly women. J Gerontol A Biol Sci Med Sci. 2000 Apr;55(4):M192–9. doi: 10.1093/gerona/55.4.M192
   PubMed Web of Science ®Google Scholar
• Raj IS, Bird SR, Shield AJ. Aging and the force-velocity relationship of muscles. Exp Gerontol. 2010 Feb;45(2):81–90. doi: 10.1016/j.exger.2009.10.013
   PubMed Web of Science ®Google Scholar
• Degens H. Chapter 19 - Human Ageing: Impact on Muscle Force and Power. In: Jerzy AZ, editor. Muscle and Exercise Physiology. Amsterdam (The Netherlands): Academic Press; 2019. p. 423–432. doi: 10.1016/B978-0-12-814593-7.00019-0
   Google Scholar
• Murton AJ, Marimuthu K, Mallinson JE, et al. Obesity appears to be associated with altered muscle protein synthetic and breakdown responses to increased Nutrient delivery in older men, but not reduced muscle mass or contractile function. Diabetes. 2015 Sep;64(9):3160–3171. doi: 10.2337/db15-0021
   PubMed Web of Science ®Google Scholar
• Dalle S, Rossmeislova L, Koppo K. The role of inflammation in age-related sarcopenia. Front Physiol. 2017;8:1045. doi: 10.3389/fphys.2017.01045
   PubMed Web of Science ®Google Scholar
• Ellulu MS, Patimah I, Khaza’ai H, et al. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017 Jun;13(4):851–863. doi: 10.5114/aoms.2016.58928
   PubMed Web of Science ®Google Scholar
• Erskine RM, Tomlinson DJ, Morse CI, et al. The individual and combined effects of obesity- and ageing-induced systemic inflammation on human skeletal muscle properties. Int J Obes (Lond). 2017 Jan;41(1):102–111. doi: 10.1038/ijo.2016.151
   PubMed Web of Science ®Google Scholar
• Guillet C, Masgrau A, Walrand S, et al. Impaired protein metabolism: interlinks between obesity, insulin resistance and inflammation. Obes Rev. 2012 Dec;13(Suppl 2):51–57. doi: 10.1111/j.1467-789X.2012.01037.x
   PubMedGoogle Scholar
• Haran PH, Rivas DA, Fielding RA. Role and potential mechanisms of anabolic resistance in sarcopenia. J Cachexia Sarcopenia Muscle. 2012 Sep;3(3):157–162. doi: 10.1007/s13539-012-0068-4
   PubMed Web of Science ®Google Scholar
• Londhe P, Guttridge DC. Inflammation induced loss of skeletal muscle. Bone. 2015 Nov;80:131–142. doi: 10.1016/j.bone.2015.03.015
   PubMed Web of Science ®Google Scholar
• Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011 Jun;121(6):2111–2117. doi: 10.1172/JCI57132
   PubMed Web of Science ®Google Scholar
• Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. 2010;2010:1–10. doi: 10.1155/2010/289645
   Web of Science ®Google Scholar
• Rodríguez-Hernández H, Simental-Mendía LE, Rodríguez-Ramírez G, et al. Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int J Endocrinol. 2013;2013:678159. doi: 10.1155/2013/678159
   PubMed Web of Science ®Google Scholar
• Katsanos CS, Mandarino LJ. Protein metabolism in human obesity: a shift in focus from whole-body to skeletal muscle. Obesity (Silver Spring). 2011 Mar;19(3):469–475. doi: 10.1038/oby.2010.290
   PubMed Web of Science ®Google Scholar
• Castro AM, Macedo-de la Concha LE, Pantoja-Meléndez CA. Low-grade inflammation and its relation to obesity and chronic degenerative diseases. Revista Médica del Hospital General de México. 2017;80(2):101–105.
   Google Scholar
• Phillips SM, Tang JE, Moore DR. The role of milk- and soy-based protein in support of muscle protein synthesis and muscle protein accretion in young and elderly persons. J Am Coll Nutr. 2009 Aug;28(4):343–354. doi: 10.1080/07315724.2009.10718096
   PubMed Web of Science ®Google Scholar
• Heo JW, Yoo SZ, No MH, et al. Exercise training Attenuates obesity-induced skeletal muscle remodeling and mitochondria-mediated apoptosis in the skeletal muscle. Int J Environ Res Public Health. 2018 Oct 19;15(10):2301. doi: 10.3390/ijerph15102301
   PubMed Web of Science ®Google Scholar
• Bilski J, Pierzchalski P, Szczepanik M, et al. Multifactorial mechanism of sarcopenia and sarcopenic obesity. Role of physical exercise, microbiota and myokines. Cells. 2022 Jan 4;11(1):160. doi: 10.3390/cells11010160
   PubMedGoogle Scholar
• Brioche T, Pagano AF, Py G, et al. Muscle wasting and aging: Experimental models, fatty infiltrations, and prevention. Mol Aspects Med. 2016 Aug;50:56–87.
   PubMed Web of Science ®Google Scholar
• Abizanda P, Romero L, Sánchez-Jurado PM, et al. Energetics of Aging and frailty: the FRADEA study. J Gerontol A Biol Sci Med Sci. 2016 Jun;71(6):787–796. doi: 10.1093/gerona/glv182
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang X, Lau WB, et al. Adiponectin inhibits tumor necrosis factor-alpha-induced vascular inflammatory response via caveolin-mediated ceramidase recruitment and activation. Circ Res. 2014 Feb 28;114(5):792–805. doi: 10.1161/CIRCRESAHA.114.302439
   PubMed Web of Science ®Google Scholar
• ! INVALID CITATION! [139].
   Google Scholar
• Sugihara H, Teramoto N, Nakamura K, et al. Cellular senescence-mediated exacerbation of duchenne muscular dystrophy. Sci Rep. 2020 2020-Oct-12;10(1). Doi:10.1038/s41598-020-73315-6
   Web of Science ®Google Scholar
• Da Silva PFL, Ogrodnik M, Kucheryavenko O, et al. The bystander effect contributes to the accumulation of senescent cells in vivo. Aging Cell. 2019 2019-Feb-1;18(1):e12848. doi: 10.1111/acel.12848
   PubMed Web of Science ®Google Scholar
• Wan M, Gray-Gaillard EF, Elisseeff JH. Cellular senescence in musculoskeletal homeostasis, diseases, and regeneration. Bone Res. 2021 2021-Sep-10;9(1). doi: 10.1038/s41413-021-00164-y
   Web of Science ®Google Scholar
• Kawakami M, Murase T, Ogawa H, et al. Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. J Biochem. 1987 Feb;101(2):331–338. doi: 10.1093/oxfordjournals.jbchem.a121917
   PubMed Web of Science ®Google Scholar
• Leduc-Gaudet J-P, Hussain SNA, Barreiro E, et al. Mitochondrial dynamics and Mitophagy in skeletal muscle health and Aging. Int J Mol Sci. 2021 2021-Jul-30;22(15):8179. doi: 10.3390/ijms22158179
   PubMed Web of Science ®Google Scholar
• Leduc-Gaudet J-P, Picard M, Pelletier F-J, et al. Mitochondrial morphology is altered in atrophied skeletal muscle of aged mice. Oncotarget. 2015 2015-Jul-20;6(20):17923–17937. doi: 10.18632/oncotarget.4235
   PubMedGoogle Scholar
• Laforge M, Rodrigues V, Silvestre R, et al. NF-κB pathway controls mitochondrial dynamics. Cell Death Diff. 2016 2016-Jan-1;23(1):89–98. doi: 10.1038/cdd.2015.42
   PubMed Web of Science ®Google Scholar
• Montarras D, L’Honoré A, Buckingham M. Lying low but ready for action: the quiescent muscle satellite cell.FEBS J. 2013 2013-Sep-1;280(17):4036–4050. doi: 10.1111/febs.12372
   PubMed Web of Science ®Google Scholar
• Sousa-Victor P, Gutarra S, García-Prat L, et al. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature. 2014 2014-Feb-1;506(7488):316–321. doi: 10.1038/nature13013
   PubMed Web of Science ®Google Scholar
• Li CW, Yu K, Shyh‐Chang N, et al. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle. 2022 2022-Apr-1;13(2):781–794. doi: 10.1002/jcsm.12901
   PubMed Web of Science ®Google Scholar
• Samengo G, Avik A, Fedor B, et al. Age-related loss of nitric oxide synthase in skeletal muscle causes reductions in calpain S-nitrosylation that increase myofibril degradation and sarcopenia. Aging Cell. 2012 Dec;11(6):1036–1045. doi: 10.1111/acel.12003
   PubMed Web of Science ®Google Scholar
• Bjornson CR, Cheung TH, Liu L, et al. Notch signaling is necessary to maintain quiescence in adult muscle stem cells. Stem Cells. 2012 Feb;30(2):232–242. doi: 10.1002/stem.773
   PubMed Web of Science ®Google Scholar
• Orentreich N, Brind JL, Rizer RL, et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 1984 Sep;59(3):551–555. doi: 10.1210/jcem-59-3-551
   PubMed Web of Science ®Google Scholar
• Nafziger AN, Bowlin SJ, Jenkins PL, et al. Longitudinal changes in dehydroepiandrosterone concentrations in men and women. J Lab Clin Med. 1998 Apr;131(4):316–323. doi: 10.1016/S0022-2143(98)90181-0
   PubMed Web of Science ®Google Scholar
• Colleluori G, Napoli N, Phadnis U, et al. Effect of weight loss, exercise, or both on Undercarboxylated Osteocalcin and insulin secretion in Frail, obese older adults. Oxid Med Cell Longevity. 2017 2017-Jan-1;2017:1–12.
   Web of Science ®Google Scholar
• Kang SY, Lim GE, Kim YK, et al. Association between sarcopenic obesity and metabolic syndrome in postmenopausal women: a cross-sectional study based on the Korean national health and nutritional examination surveys from 2008 to 2011. J Bone Metab. 2017 Feb;24(1):9–14. doi: 10.11005/jbm.2017.24.1.9
   PubMedGoogle Scholar
• Gambacciani M, Ciaponi M, Cappagli B, et al. Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy. Maturitas. 2001 Aug 25;39(2):125–132. doi: 10.1016/S0378-5122(01)00194-3
   PubMed Web of Science ®Google Scholar
• Enns DL, Tiidus PM. The influence of estrogen on skeletal muscle: sex matters. Sports Med. 2010 Jan 1;40(1):41–58. doi: 10.2165/11319760-000000000-00000
   PubMed Web of Science ®Google Scholar
• Yeap BB. Are declining testosterone levels a major risk factor for ill-health in aging men? Int J Impot Res. 2009;21(1):24–36. doi: 10.1038/ijir.2008.60
   PubMed Web of Science ®Google Scholar
• Ketchem JM, Bowman EJ, Isales CM. Male sex hormones, aging, and inflammation. Biogerontology. 2023 Feb;24(1):1–25. doi: 10.1007/s10522-022-10002-1
   PubMed Web of Science ®Google Scholar
• Brodsky IG, Balagopal P, Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men–a clinical research center study. J Clin Endocrinol Metab. 1996 Oct;81(10):3469–3475. doi: 10.1210/jcem.81.10.8855787
   PubMed Web of Science ®Google Scholar
• Pronsato L, Milanesi L, Vasconsuelo A. Testosterone induces up-regulation of mitochondrial gene expression in murine C2C12 skeletal muscle cells accompanied by an increase of nuclear respiratory factor-1 and its downstream effectors. Mol Cell Endocrinol. 2020 Jan 15;500:110631. doi: 10.1016/j.mce.2019.110631
   PubMed Web of Science ®Google Scholar
• LeBlanc ES, Wang PY, Lee CG, et al. Higher testosterone levels are associated with less loss of lean body mass in older men. J Clin Endocrinol Metab. 2011 Dec;96(12):3855–3863. doi: 10.1210/jc.2011-0312
   PubMed Web of Science ®Google Scholar
• Miller KK. Androgen deficiency: effects on body composition. Pituitary. 2009;12(2):116–124. doi: 10.1007/s11102-008-0121-7
   PubMed Web of Science ®Google Scholar
• Isidori AM, Giannetta E, Greco EA, et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf). 2005 Sep;63(3):280–293. doi: 10.1111/j.1365-2265.2005.02339.x
   PubMed Web of Science ®Google Scholar
• Bhasin S, Woodhouse L, Casaburi R, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab. 2005 Feb;90(2):678–688. doi: 10.1210/jc.2004-1184
   PubMed Web of Science ®Google Scholar
• Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab. 1999 Aug;84(8):2647–2653. doi: 10.1210/jc.84.8.2647
   PubMed Web of Science ®Google Scholar
• Ferrando AA, Sheffield-Moore M, Yeckel CW, et al. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab. 2002 Mar;282(3):E601–7. doi: 10.1152/ajpendo.00362.2001
   PubMed Web of Science ®Google Scholar
• Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016 Feb 18;374(7):611–624. doi: 10.1056/NEJMoa1506119
   PubMed Web of Science ®Google Scholar
• Bhasin S, Travison TG, Storer TW, et al. Effect of testosterone supplementation with and without a dual 5α-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial. JAMA. 2012 Mar 7;307(9):931–939. doi: 10.1001/jama.2012.227
   PubMed Web of Science ®Google Scholar
• Correa C, Bieger P, Perry IS, et al. Testosterone supplementation on sarcopenia components in chronic patients: a systematic review and meta-analysis. Curr Pharm Des. 2022;28(7):586–594. doi: 10.2174/1381612827666211115155541
   PubMedGoogle Scholar
• Rolland Y, Czerwinski S, Abellan Van Kan G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12(7):433–450. doi: 10.1007/BF02982704
   PubMed Web of Science ®Google Scholar
• Weinsier RL, Schutz Y, Bracco D. Reexamination of the relationship of resting metabolic rate to fat-free mass and to the metabolically active components of fat-free mass in humans. Am J Clin Nutr. 1992 Apr;55(4):790–794. doi: 10.1093/ajcn/55.4.790
   PubMed Web of Science ®Google Scholar
• Lettieri-Barbato D, Aquilano K. Aging and immunometabolic adaptations to thermogenesis. Ageing Res Rev. 2020 Nov;63:101143. doi: 10.1016/j.arr.2020.101143
   PubMed Web of Science ®Google Scholar
• Cannon B, Nedergaard J. Nonshivering thermogenesis and its adequate measurement in metabolic studies. J Exp Biol. 2011 Jan 15;214(Pt 2):242–253. doi: 10.1242/jeb.050989
   PubMed Web of Science ®Google Scholar
• Dulloo AG, Seydoux J, Jacquet J. Adaptive thermogenesis and uncoupling proteins: a reappraisal of their roles in fat metabolism and energy balance. Physiol Behav. 2004 Dec 30;83(4):587–602. doi: 10.1016/j.physbeh.2004.07.028
   PubMed Web of Science ®Google Scholar
• Doucet E, Imbeault P, St-Pierre S, et al. Appetite after weight loss by energy restriction and a low-fat diet-exercise follow-up. Int J Obes Relat Metab Disord. 2000 Jul;24(7):906–914. doi: 10.1038/sj.ijo.0801251
   PubMed Web of Science ®Google Scholar
• Doucet E, St Pierre S, Alméras N, et al. Changes in energy expenditure and substrate oxidation resulting from weight loss in obese men and women: is there an important contribution of leptin? J Clin Endocrinol Metab. 2000 Apr;85(4):1550–1556. doi: 10.1210/jc.85.4.1550
   PubMed Web of Science ®Google Scholar
• Bray GA. Effect of caloric restriction on energy expenditure in obese patients. Lancet. 1969 Aug 23;2(7617):397–398. doi: 10.1016/S0140-6736(69)90109-3
   PubMed Web of Science ®Google Scholar
• Major GC, Doucet E, Trayhurn P, et al. Clinical significance of adaptive thermogenesis. Int J Obes (Lond). 2007 Feb;31(2):204–212. doi: 10.1038/sj.ijo.0803523
   PubMed Web of Science ®Google Scholar
• Rosenbaum M, Hirsch J, Gallagher DA, et al. Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr. 2008 Oct;88(4):906–912. doi: 10.1093/ajcn/88.4.906
   PubMed Web of Science ®Google Scholar
• Tremblay A, Royer MM, Chaput JP, et al. Adaptive thermogenesis can make a difference in the ability of obese individuals to lose body weight. Int J Obes (Lond). 2013 Jun;37(6):759–764. doi: 10.1038/ijo.2012.124
   PubMed Web of Science ®Google Scholar
• Astrup A, Gøtzsche PC, van de Werken K, et al. Meta-analysis of resting metabolic rate in formerly obese subjects. Am J Clin Nutr. 1999 Jun;69(6):1117–1122. doi: 10.1093/ajcn/69.6.1117
   PubMed Web of Science ®Google Scholar
• Roth SM, Martel GF, Ivey FM, et al. Ultrastructural muscle damage in young vs. older men after high-volume, heavy-resistance strength training. J Appl Physiol (1985). 1999 Jun;86(6):1833–1840. doi: 10.1152/jappl.1999.86.6.1833
   PubMed Web of Science ®Google Scholar
• Klem ML, Wing RR, Lang W, et al. Does weight loss maintenance become easier over time? Obes Res. 2000 Sep;8(6):438–444. doi: 10.1038/oby.2000.54
   PubMedGoogle Scholar
• Wing RR, Hill JO. Successful weight loss maintenance. Annu Rev Nutr. 2001;21(1):323–341. doi: 10.1146/annurev.nutr.21.1.323
   PubMed Web of Science ®Google Scholar
• Scott D, Cumming R, Naganathan V, et al. Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: the Concord health and ageing in men project. Exp Gerontol. 2018 2018-Jul-1;108:99–105.
   PubMed Web of Science ®Google Scholar
• Stefan N, Schick F, Birkenfeld AL, et al. The role of hepatokines in NAFLD. Cell Metab. 2023 Feb 7;35(2):236–252. doi: 10.1016/j.cmet.2023.01.006
   PubMed Web of Science ®Google Scholar
• Justice JN, Ferrucci L, Newman AB, et al. A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME biomarkers Workgroup. Geroscience. 2018 12;40(5–6):419–436. doi: 10.1007/s11357-018-0042-y
   PubMed Web of Science ®Google Scholar
• Semenova EA, Pranckeviciene E, Bondareva EA, et al. Identification and characterization of genomic predictors of sarcopenia and sarcopenic obesity using UK Biobank data. Nutrients. 2023 Feb 2;15(3):758. doi: 10.3390/nu15030758
   PubMed Web of Science ®Google Scholar
• Dowling L, Duseja A, Vilaca T, et al. MicroRNAs in obesity, sarcopenia, and commonalities for sarcopenic obesity: a systematic review. J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):68–85. doi: 10.1002/jcsm.12878
   PubMed Web of Science ®Google Scholar
• Stefan N, Schulze MB. Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment. Lancet Diabetes Endocrinol. 2023 Jun;11(6):426–440. doi: 10.1016/S2213-8587(23)00086-4
   PubMed Web of Science ®Google Scholar
• Poggiogalle E, Migliaccio S, Lenzi A, et al. Treatment of body composition changes in obese and overweight older adults: insight into the phenotype of sarcopenic obesity. Endocrine. 2014 2014-Dec-1;47(3):699–716. doi: 10.1007/s12020-014-0315-x
   PubMed Web of Science ®Google Scholar
• Poggiogalle E, Parrinello E, Barazzoni R, et al. Therapeutic strategies for sarcopenic obesity: a systematic review. Curr Opin Clin Nutr Metab Care. 2021 Jan;24(1):33–41. doi: 10.1097/MCO.0000000000000714
   PubMed Web of Science ®Google Scholar
• Melson E, Miras AD, Papamargaritis D. Future therapies for obesity. Clin Med. 2023 Jul;23(4):337–346. doi: 10.7861/clinmed.2023-0144
   PubMed Web of Science ®Google Scholar
• Heymsfield SB, Coleman LA, Miller R, et al. Effect of bimagrumab vs Placebo on body fat mass among adults with type 2 Diabetes and obesity: a Phase 2 randomized clinical trial. JAMA Netw Open. 2021 Jan 4;4(1):e2033457. doi: 10.1001/jamanetworkopen.2020.33457
   PubMed Web of Science ®Google Scholar